U.S. markets open in 4 hours 29 minutes

Abacus Health Products, Inc. (ABCS.CN)

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Add to watchlist
6.51-0.59 (-8.31%)
At close: 3:56PM EDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7.10
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume166,536
Market Cap140.479M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateApr 29, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Charlotte's Web Acquires Abacus Health Products
      PR Newswire

      Charlotte's Web Acquires Abacus Health Products

      Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") (TSX: CWEB) (OTCQX: CWBHF), the company behind the world's most trusted hemp extract, and Abacus Health Products, Inc. ("Abacus") (CSE: ABCS) (OTCQB: ABAHF), a leader in over-the-counter topical products combining active pharmaceutical ingredients with hemp extract, are pleased to announce that they have completed the previously-announced plan of arrangement (the "Arrangement"). Pursuant to the Arrangement, Charlotte's Web acquired all the issued and outstanding subordinate voting shares of Abacus (the "Abacus Shares"). All the outstanding proportionate voting shares of Abacus were converted into Abacus Shares prior to closing of the Arrangement. Pursuant to the Arrangement, holders of Abacus Shares received 0.85 (the "Exchange Ratio") of a common share of Charlotte's Web for each Abacus Share held at the time of closing.

    • Abacus Health Products Receives Court Approval for Arrangement with Charlotte’s Web
      Business Wire

      Abacus Health Products Receives Court Approval for Arrangement with Charlotte’s Web

      Abacus Health Products Inc. receives final court order approving its acquisition by Charlotte's Web Holdings Inc.

    • Abacus Health Products’ Shareholders Approve Arrangement with Charlotte’s Web
      Business Wire

      Abacus Health Products’ Shareholders Approve Arrangement with Charlotte’s Web

      Abacus Health Products Inc. shareholders approve the company's acquisition by Charlotte's Web Holdings Inc.